National Study AEC COVID-19

National Study AEC COVID-19 on Patients Undergoing Surgical Intervention During the SARS-CoV-2 Pandemic.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04573868

Enrollment

1000

Registered

2020-10-05

Start date

2020-03-01

Completion date

2020-09-30

Last updated

2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mortality

Keywords

COVID, Surgery

Brief summary

Currently there is an important need to know the evolution, results and associated mortality of patients undergoing surgical intervention in Spain during the SARS-CoV-2 pandemic. With a national data collection, information could be obtained to guide the management of this group of complex patients operated on during the COVID-19 pandemic, with the aim of improving their treatment in the event of a second wave. The great spread of the virus and the difficulty in controlling it over time makes it a high priority for the scientific community in order to face new outbreaks. The national study AEC COVID-19 is a collaborative study (in the style of those carried out at European level such as Eurosurg, Globalsurg, etc.) that aims to know the evolution, results and associated mortality of patients undergoing surgical intervention in Spain during the SARS-CoV-2 pandemic. It is an observational study, with anonymized and coded data, which aims to demonstrate the following hypotheses: * Patients with COVID-19 have high mortality. * Patients with both oncological and benign pathologies have high morbidity. The situation / follow-up at 7 days and 30 days after the intervention will be included in each patient.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

14 Years to No maximum

Healthy volunteers

Inclusion criteria

Adult patients who undergo a surgical procedure during the pandemic

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Mortality	30 days	Patient who died after surgery 30 days after the surgical procedure

Secondary

Measure	Time frame	Description
Morbidity	30 days	Complictaions after surgery

Countries

Spain

Contacts

Primary ContactSalvador Morales-Conde

smoralesc@gmail.com670238582

Outcome results